As the contract research organization (CRO) industry experiences change with large CROs consolidating through mergers and acquisitions, small to midsize CROs open new opportunities for clinical researchers through differentiated strategies and organizational diversity. Peter Benton, President and Chief Operating Officer at Worldwide Clinical Trials, discusses this in an Applied Clinical Trials article.
Authors:
Peter Benton, MBA
President and Chief Executive Officer
